Diuretics Practice Questions

Q: Side effects of thiazide diuretics include all of the following except?

Hypocalcemia. ***Hypocalcemia*** - Thiazide diuretics are known to cause **hypercalcemia** (increased calcium reabsorption), NOT hypocalcemia, due to their action on the distal convoluted tubule. - This property makes them useful in treating conditions like **idiopathic hypercalciuria** and **calcium-containing kidney stones**. - The mechanism involves enhanced passive calcium reabsorption in the proximal tubule and active reabsorption in the distal tubule. *Hyponatremia* - Thiazide diuretics impair the kidney's ability to dilute urine and reabsorb sodium in the distal tubule, leading to **increased sodium excretion** and potential hyponatremia. - This effect is more pronounced in **elderly patients** and those with increased free water intake. - Hyponatremia is one of the most common electrolyte disturbances with thiazides. *Hypokalemia* - Thiazides increase the delivery of sodium and water to the collecting duct, leading to increased activity of the **renin-angiotensin-aldosterone system** and enhanced potassium secretion. - This results in **potassium wasting** and hypokalemia, which may require potassium supplementation or combination with potassium-sparing diuretics. *Erectile dysfunction* - Thiazide diuretics can cause **erectile dysfunction** through mechanisms including effects on vascular smooth muscle, reduced blood flow, and possible hormonal effects. - This is a common side effect reported in male patients using these medications for hypertension and may affect compliance.

Q: Which diuretic exhibits paradoxical antidiuretic activity in diabetes insipidus?

Thiazide diuretics. ***Thiazide diuretics*** - Thiazides cause a modest **volume depletion**, leading to increased proximal tubular reabsorption of water and solutes [1]. - They also lower the **glomerular filtration rate**, further reducing the amount of fluid delivered to the collecting ducts, thus paradoxically reducing urine output in diabetes insipidus [2]. - This effect is particularly useful in **nephrogenic diabetes insipidus**, where the kidneys cannot respond to ADH [2]. *Potassium-sparing diuretics (Triamterene)* - Triamterene is a **potassium-sparing diuretic** that blocks epithelial sodium channels in the late distal tubule and collecting duct. - It increases sodium and water excretion, which would worsen, not improve, the polyuria of diabetes insipidus. *Aldosterone antagonists (Spironolactone)* - Spironolactone is a **mineralocorticoid receptor antagonist** that increases sodium and water excretion while conserving potassium in the collecting duct. - Its primary action is to counteract aldosterone, and it does not exhibit the paradoxical antidiuretic effect seen with thiazides in diabetes insipidus. *Loop diuretics (Furosemide)* - Loop diuretics like furosemide act on the **thick ascending limb of the loop of Henle** to inhibit sodium, potassium, and chloride reabsorption. - They cause significant diuresis and would **exacerbate the polyuria** in patients with diabetes insipidus, rather than improving it.

Q: Which medication is commonly used in heart failure that also has aldosterone antagonistic properties?

Spironolactone. ***Spironolactone*** - **Spironolactone** is a **potassium-sparing diuretic** that acts as a **competitive antagonist of aldosterone** receptors, primarily in the collecting ducts of the kidneys. - This action leads to increased excretion of sodium and water, and retention of potassium, which is beneficial in **heart failure** by reducing fluid overload and mitigating the detrimental effects of aldosterone on cardiac remodeling. *Carvedilol* - **Carvedilol** is a **beta-blocker** with additional **alpha-1 blocking** properties, commonly used in heart failure to reduce heart rate, blood pressure, and myocardial oxygen demand. - It does not possess significant aldosterone antagonistic properties. *Sacubitril/Valsartan* - **Sacubitril/Valsartan** is an **angiotensin receptor-neprilysin inhibitor (ARNI)**. Valsartan is an **angiotensin receptor blocker (ARB)**, and sacubitril inhibits neprilysin, an enzyme that degrades natriuretic peptides. - While it modulates the **renin-angiotensin-aldosterone system (RAAS)** and is highly effective in heart failure, it does not directly antagonize aldosterone receptors. *Abiraterone* - **Abiraterone** is an **androgen-biosynthesis inhibitor** used in the treatment of **prostate cancer**. - Its primary mechanism involves inhibiting **CYP17**, an enzyme critical for androgen production, and it has no role in the management of heart failure or aldosterone antagonism.

Q: Which of the following statements about Conivaptan is correct?

It is a vasopressin antagonist.. ***It is a vasopressin antagonist.*** * **Conivaptan** is a non-peptide, dual **vasopressin V1A and V2 receptor antagonist**, meaning it blocks the action of vasopressin. * By blocking vasopressin, it promotes **aquaresis** (excretion of solute-free water), which is beneficial in conditions like **hyponatremia**. * *It selectively acts on V2 receptors.* * **Conivaptan** is a **dual antagonist**, blocking both **V1A and V2 receptors**, not just V2. * **Tolvaptan**, in contrast, is a selective **V2 receptor antagonist**. * *It is administered orally.* * **Conivaptan** is typically administered intravenously, particularly in hospital settings for acute hyponatremia. * **Tolvaptan** is the orally administered vasopressin antagonist. * *All of the options.* * Since Conivaptan is not selectively acting on V2 receptors and is not administered orally, this option is incorrect.

Q: Which of the following is an aldosterone antagonist?

Eplerenone. ***Eplerenone*** - **Eplerenone** acts as a **selective aldosterone antagonist**, blocking aldosterone receptors in epithelial tissues and various non-epithelial tissues. - Due to its selectivity, it causes fewer **endocrine side effects** (like gynecomastia or impotence) compared to spironolactone. *Fenoldopam* - **Fenoldopam** is a **dopamine D1-receptor agonist** that causes peripheral vasodilation and increased renal blood flow, primarily used for severe hypertension. - It does not directly interact with the **aldosterone pathway** and is not an aldosterone antagonist. *Furosemide* - **Furosemide** is a **loop diuretic** that inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, leading to increased excretion of water, sodium, potassium, and chloride. - It does not directly block aldosterone's action but rather affects electrolyte reabsorption higher up in the nephron. *Deoxycorticosterone* - **Deoxycorticosterone (DOC)** is a **mineralocorticoid** hormone, a precursor to aldosterone, and functions as an agonist at the mineralocorticoid receptor. - It actually mimics the effects of aldosterone, promoting sodium and water retention, and is therefore not an aldosterone antagonist.

Q: The longest-acting loop diuretic is:

Torsemide. ***Torsemide*** - **Torsemide** has a longer half-life (3.5 hours) compared to other loop diuretics, leading to a more sustained diuretic effect. - Its prolonged action contributes to its classification as the **longest-acting loop diuretic**, making it suitable for less frequent dosing. *Bumetanide* - **Bumetanide** has a rapid onset and short duration of action, with a half-life of about 1 to 1.5 hours. - While it is a potent loop diuretic, its duration of action is significantly shorter than that of torsemide. *Ethacrynic acid* - **Ethacrynic acid** has a duration of action of approximately 6-8 hours and a half-life of 2-4 hours. - Although it is unique as a non-sulfonamide loop diuretic, its duration of action is not the longest among this class. *Furosemide* - **Furosemide** typically has a half-life of about 1.5 to 2 hours, resulting in a relatively short duration of action (6-8 hours). - It is frequently administered multiple times a day due to its short-acting nature.

Q: Which drug is given to prevent acute mountain sickness?

Acetazolamide. ***Acetazolamide*** - This drug is a **carbonic anhydrase inhibitor** that acidifies the blood and causes compensatory hyperventilation, increasing oxygenation. - It is the **first-line prophylactic agent** for acute mountain sickness (AMS) and is best started 24-48 hours before ascent. - Most effective and widely recommended for AMS prevention. *Digoxin* - This is a **cardiac glycoside** used to treat heart failure and irregular heartbeats. - Its mechanism of action is unrelated to the physiological changes that cause acute mountain sickness. *Diltiazem* - This is a **calcium channel blocker** primarily used for hypertension, angina, and certain arrhythmias. - It has no known role in the prevention or treatment of acute mountain sickness. *Dexamethasone* - While **dexamethasone** can be used for AMS prophylaxis, it is typically reserved as an **alternative agent** when acetazolamide is contraindicated or not tolerated. - It is more commonly used for **treatment** of severe altitude illness including **High Altitude Cerebral Edema (HACE)** and **High Altitude Pulmonary Edema (HAPE)**. - **Acetazolamide remains the preferred first-line prophylactic agent** due to its mechanism of action that directly addresses the underlying pathophysiology of AMS.

Q: Which of the following is not associated with thiazide diuretics?

Hypercalciuria. ***Hypercalciuria*** - Thiazide diuretics are known to **decrease urinary calcium excretion** (hypocalciuria), not increase it (hypercalciuria). - This effect makes them useful in preventing **recurrent calcium kidney stones**. *Hyponatremia* - Thiazides can cause **hyponatremia** by increasing the reabsorption of water (via ADH) and impairing salt reabsorption in the distal tubule, leading to reduced free water clearance. - This side effect is a common concern, especially in elderly patients. *Hypokalemia* - Thiazide diuretics inhibit sodium and chloride reabsorption in the distal convoluted tubule, leading to increased delivery of sodium to the collecting duct. - This increased sodium delivery, coupled with increased aldosterone secretion, promotes **potassium secretion** and can result in **hypokalemia**. *Hyperuricemia* - Thiazide diuretics compete with uric acid for secretion in the **proximal tubule**, leading to reduced uric acid excretion. - This can elevate **serum uric acid levels** and potentially precipitate gout attacks.

Q: Which of the following statements about furosemide is TRUE?

It is used in the treatment of pulmonary edema.. ***It is used in the treatment of pulmonary edema.*** - **Furosemide** is a potent **loop diuretic** that rapidly reduces **fluid overload**, making it highly effective in managing acute **pulmonary edema**. - Its ability to induce significant diuresis helps decrease systemic and pulmonary venous congestion, thereby improving respiratory function. *It can only be administered intravenously.* - While it can be administered **intravenously** for rapid effect, **furosemide** is also commonly available and effective when given **orally** [1]. - Oral administration is preferred for chronic management and outpatient settings. *It causes minimal diuresis.* - **Furosemide** is known as a **high-ceiling loop diuretic** because it produces a significant and rapid diuresis, not minimal [2]. - It works by inhibiting the **sodium-potassium-2 chloride cotransporter** [3] in the **thick ascending limb of the loop of Henle**, leading to substantial fluid and electrolyte excretion. *It primarily acts on the distal convoluted tubule.* - **Furosemide** primarily acts on the **thick ascending limb of the loop of Henle**, not the distal convoluted tubule [2]. - Diuretics that primarily act on the distal convoluted tubule are **thiazide diuretics**, such as hydrochlorothiazide [2].

Question 1

Side effects of thiazide diuretics include all of the following except?

Accepted Answer

Hypocalcemia

Answer

Hypokalemia

Answer

Erectile dysfunction

Answer

Hyponatremia

Question 2

Which diuretic exhibits paradoxical antidiuretic activity in diabetes insipidus?

Accepted Answer

Thiazide diuretics

Answer

Aldosterone antagonists (Spironolactone)

Answer

Loop diuretics (Furosemide)

Answer

Potassium-sparing diuretics (Triamterene)

Question 3

Which medication is commonly used in heart failure that also has aldosterone antagonistic properties?

Accepted Answer

Spironolactone

Answer

Carvedilol

Answer

Abiraterone

Answer

Sacubitril/Valsartan

Question 4

Which of the following statements about Conivaptan is correct?

Accepted Answer

It is a vasopressin antagonist.

Answer

It selectively acts on V2 receptors.

Answer

It is administered orally.

Answer

All of the options.

Question 5

Which of the following is an aldosterone antagonist?

Accepted Answer

Eplerenone

Answer

Furosemide

Answer

Fenoldopam

Answer

Deoxycorticosterone

Question 6

How does amiloride differ from spironolactone in its mechanism of action?

Accepted Answer

It acts primarily on the luminal side of the collecting duct cells.

Answer

It is effective in conditions with normal or low aldosterone levels.

Answer

It typically does not cause hypokalemia.

Answer

It has a different mechanism of action that does not involve aldosterone receptor blockade.

Question 7

The longest-acting loop diuretic is:

Accepted Answer

Torsemide

Answer

Bumetanide

Answer

Ethacrynic acid

Answer

Furosemide

Question 8

Which drug is given to prevent acute mountain sickness?

Accepted Answer

Acetazolamide

Answer

Diltiazem

Answer

Digoxin

Answer

Dexamethasone

Question 9

Which of the following is not associated with thiazide diuretics?

Accepted Answer

Hypercalciuria

Answer

Hyponatremia

Answer

Hypokalemia

Answer

Hyperuricemia

Question 10

Which of the following statements about furosemide is TRUE?

Accepted Answer

It is used in the treatment of pulmonary edema.

Answer

It causes minimal diuresis.

Answer

It can only be administered intravenously.

Answer

It primarily acts on the distal convoluted tubule.

Diuretics — MCQs

Diuretics — MCQs

On this page

Practice by Chapter

Want unlimited practice?